Serologic Screening for Genital Herpes Infection: US Preventive Services Task Force Reaffirmation Recommendation Statement.

MLA

Mangione, Carol M., et al. “Serologic Screening for Genital Herpes Infection: US Preventive Services Task Force Reaffirmation Recommendation Statement.” JAMA, vol. 329, no. 6, Feb. 2023, pp. 502–07. EBSCOhost, https://doi.org/10.1001/jama.2023.0057.

APA

Mangione, C. M., Barry, M. J., Nicholson, W. K., Cabana, M., Chelmow, D., Coker, T. R., Davis, E. M., Donahue, K. E., Jaén, C. R., Kubik, M., Li, L., Ogedegbe, G., Pbert, L., Ruiz, J. M., Stevermer, J., & Wong, J. B. (2023). Serologic Screening for Genital Herpes Infection: US Preventive Services Task Force Reaffirmation Recommendation Statement. JAMA, 329(6), 502–507. https://doi.org/10.1001/jama.2023.0057

Chicago

Mangione, Carol M, Michael J Barry, Wanda K Nicholson, Michael Cabana, David Chelmow, Tumaini Rucker Coker, Esa M Davis, et al. 2023. “Serologic Screening for Genital Herpes Infection: US Preventive Services Task Force Reaffirmation Recommendation Statement.” JAMA 329 (6): 502–7. doi:10.1001/jama.2023.0057.